Zurich, Switzerland – AUGMENTICON AG, a privately held technology company developing Augmented-/Mixed-Reality (AR-/MR)-tools, announces the certification of its quality management system by TUV Rheinland according to the ISO 9001:2015 standard. Augmenticon’s decision to work towards the ISO 9001:2015 standard was driven by more than 20 years of experience with pharmaceutical quality management systems and a firm commitment to continually improving our products and services.
“Achieving ISO 9001:2015 certification is fantastic news and means our customers have complete assurance that our products operate to the highest quality standard and our services meet their expectations reliably and consistently .” says Matthias Friebe, President of the Board of Directors.
Christian Schmidt, Chief Compliance Officer of AUGMENTICON states: “I am extremely proud of my team for their achievement, which proves our commitment to ensuring quality and providing the best possible service to our clients. We are dedicated to constant improvement and development. Achieving and maintaining an ISO 9001:2015 accreditation ensures that we have the processes and systems in place for this.”
About AUGMENTICON SHARE / ASSYST – The AR-/MR supported technology enables a fully remote-controlled installation, repair, and maintenance support, reduced response-times, lower costs (e.g. travel & accommodation etc.), and full online documentation. Furthermore, the technology brings a high potential for online-training, thus helps to shorten training time, and ensures smooth radio-labeling w/o batch failures.
About AUGMENTICON – AUGMENTICON, a driver in the application of novel INDUSTRY-4.0 solutions offers applications for the optimization of industrial radiopharmaceutical operations. The company, founded in 2019, is based in Glattbrugg/Switzerland and is developing and commercializing Augmented-/Mixed-Reality based tools for a fully remote-controlled manufacturing guidance, -control, and (GMP-)-documentation. It`s management has a combined 60+ years of expertise in the development, manufacturing, release, marketing, and commercialization of (radio-) pharmaceuticals. To learn more about AUGMENTICON please visit us at: https://www.augmenticon.ch.